uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung

Clinical trial NCT02755675 · UNKNOWN

Trial details

NCT number: NCT02755675
Sponsor: Rigshospitalet, Denmark
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Malignant Pleural Mesothelioma Large Cell Neuroendocrine Carcinoma of the Lung

Start date: 2016-04-01
Primary completion: 2023-04-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.